# Efficacy of the Infusion of Donor Plasma in COVID-19 Infection

> **NCT05247307** · PHASE3 · TERMINATED · sponsor: **Hospital Galdakao-Usansolo** · enrollment: 93 (actual)

## Conditions studied

- COVID-19

## Interventions

- **BIOLOGICAL:** convalescent plasma infusion covid 19

## Key facts

- **NCT ID:** NCT05247307
- **Lead sponsor:** Hospital Galdakao-Usansolo
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-03-31
- **Primary completion:** 2021-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 93 (ACTUAL)
- **Why stopped:** Lack of efficacy of treatment tested
- **Last updated:** 2022-03-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05247307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05247307, "Efficacy of the Infusion of Donor Plasma in COVID-19 Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05247307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*